Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | UCART20X22 |
Synonyms | |
Therapy Description |
UCART20X22 consists of a preparation of allogeneic T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets both CD20 and CD22, which potentially leads to antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr 551). |